Produşii finali de glicare avansată în evoluţia clinică a glomerulonefritei la copii
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1015 21
Ultima descărcare din IBN:
2023-12-21 00:20
Căutarea după subiecte
similare conform CZU
616.611-053.2-036-07 (2)
Заболевания опорно-двигательной системы. Скелет и мышечная система (392)
SM ISO690:2012
CIUNTU, Angela. Produşii finali de glicare avansată în evoluţia clinică a glomerulonefritei la copii. In: Buletin de Perinatologie, 2016, nr. 4(72), pp. 49-52. ISSN 1810-5289.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Buletin de Perinatologie
Numărul 4(72) / 2016 / ISSN 1810-5289

Produşii finali de glicare avansată în evoluţia clinică a glomerulonefritei la copii
CZU: 616.611-053.2-036-07

Pag. 49-52

Ciuntu Angela12
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 IMSP Institutul Mamei şi Copiluluii
 
Proiecte:
 
Disponibil în IBN: 28 decembrie 2016


Rezumat

We studied the concentration of advanced glycation end products of AGEs in the blood of 80 children with primary glomerulonephritis (GN) with various clinical stages of the disease. In children with various forms of GN in the acute phase of the disease are registered a significant increase in the blood concentration of AGEs. In the acute phase of clinical manifestations in patients with steroid-sensitive nephrotic syndrome (NS), the level of AGEs trustworthy increases by 2.3 times, and in steroid-resistant (NR) by 1.6 times as compared to the control group. In remission the level of AGEs decreases in comparison with the initial level, and does not differ from it in the control group. Determination of AGEs in the blood concentration can be used to monitor the activity of the disease process in children with various variants GN, as well as to monitor the effectiveness of the therapeutic interventions.